Comparison of conventional doxorubicin with liposome encapsulated doxorubicin as a treatment of breast cancer-a review

Comparison of conventional doxorubicin with liposome encapsulated doxorubicin as a treatment of breast cancer-a review

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Détails bibliographiques
Auteur principal:	Akter, Honufa
Autres auteurs:	Sharmin, Sabrina
Format:	Thèse
Langue:	English
Publié:	Brac University 2024
Sujets:	Doxorubicin Breast cancer Liposome Liposomal doxorubicin Cardiotoxicity Metastasis Breast cancer > Treatment.
Accès en ligne:	http://hdl.handle.net/10361/23619

Documents similaires

Breast cancer therapy through Liposomal drug delivery system
par: Ome, Nusrat Jahan
Publié: (2024)

Potential of liposomes for the treatment of lung cancer- a review
par: Mim, Shanzida
Publié: (2023)

Recent advancement on breast cancer detection and treatment
par: Rahman, Sanjida
Publié: (2023)

A review of Breast Cancer risk factor assessment on women in developing countries, cancer drug resistance, and Breast Cancer treatment in Bangladesh
par: Raihan, Dilraj
Publié: (2024)

Natural products and their combinatory effects in breast cancer treatment
par: Siddique, Md. Ayman
Publié: (2021)

Targeted therapeutic options in the treatment of Breast Cancer
par: Alam, Kazi Tasnuva
Publié: (2022)

Breast cancer awareness seminars
par: Anwer Khan Modern Medical College
Publié: (2016)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
par: Nahar, Kamrun
Publié: (2023)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
par: Chakraborty, Anuradha
Publié: (2024)

A review on triple-negative breast cancer and its potential treatment
par: Niasa, Jannatul Ferdous
Publié: (2023)

Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer
par: Shobnam, Sohana
Publié: (2024)

The impact of breast cancer on women’s lives in Bangladesh
par: Mobashera, Tayeeba Tum
Publié: (2024)

Machine learning as an indicator for breast cancer prediction
par: Shadman, Tahsin Mohammed, et autres
Publié: (2019)

Breast cancer in low-resource settings: Prioritizing the awareness and access programmes to overcome sociocultural and economic barriers for early detection and improved outcomes
par: Iqbal, Mohammad Shamim, et autres
Publié: (2017)

Targeting DHFR in breast cancer: exploring expression patterns and identifying potential inhibitors through docking studies
par: Araf, Faiaz Fahim
Publié: (2024)

Pathway analysis of Disease-Gene associated network in the human breast cancer
par: Lamia
Publié: (2020)

Anthracycline induced cardiotoxicity: A systematic review
par: Azam, Faruque
Publié: (2018)

Breast cancer in South Asia: a Bangladeshi perspective
par: Hossain, Mohammad Sorowar, et autres
Publié: (2017)

Early detection of breast cancer using machine learning
par: Fuad, Wasi Mohammad
Publié: (2019)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
par: Nuha, Nabiha Tahsin
Publié: (2024)

A review on the potential of repurposing of metformin for colon cancer and breast cancer
par: Oishy, Jannatun Noor
Publié: (2024)

Breast cancer prediction using different machine learning models
par: Khandker Al- Muhaimin, et autres
Publié: (2020)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
par: Mirza, Maisa Tasnim
Publié: (2023)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
par: Hasan, Sakib
Publié: (2024)

Association of BRCA1, BRCA2, RAD51, and HER2 gene polymorphisms with the breast cancer risk in the Bangladeshi population
par: Parvin, Salma, et autres
Publié: (2016)

Oncogenes: new targets in cancer treatment
par: Chowdhury, Waseka Shams
Publié: (2020)

Current practice and approaches of immunotherapy in Cancer treatment
par: Khondokar, Faiza
Publié: (2022)

Machine learning In breast cancer prognosis and prediction
par: Chowdhury, Shah Abul Hasnat, et autres
Publié: (2023)

RIPK pathway, as a potential target, for cancer treatment - a review
par: Jahan, Nusrat
Publié: (2024)

Biosimilar in lymphoma treatment
par: Tanisha, Mehrin Haque
Publié: (2021)

A comprehensive review on drug repurposing in cancer treatment
par: Sarkar, Onusree
Publié: (2024)

Potential phytochemicals and dietary components for the prevention and treatment of skin cancer: A review
par: Muntaha, Habibatul
Publié: (2023)

Palliative care services in cancer treatment: a study of the current scenario in Dhaka
par: Rahman, Qazi Ashrafur
Publié: (2018)

Targeting BRAFV600E in the treatment of CRC
par: Roja, Mashwiyat Samrin
Publié: (2024)

A review on recent advances in drugs for lung cancer treatment
par: Noor, Fouzia
Publié: (2024)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
par: Rahman, Tasnim
Publié: (2024)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
par: Abir, Shifaty Nur
Publié: (2024)

Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies
par: Alam, Tahera
Publié: (2024)

Evaluation of genetics of cancer predisposition in patients and efficacy of various chemotherapeutic drugs in Bangladesh
par: Hossain, Safa Binte
Publié: (2019)

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
par: Karim, Azrin
Publié: (2024)